Kilitch Drugs Ltd (KILITCH)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 360.00
% Change: -1.37% (Prev Close: 365.00)

Volume: 7,494
% Change: -70.90% (Prev Volume: 25,755)

Delivery: 5,066
Delivery % : 67.60
% Change: -74.94% (Prev Delivery: 20,215)

Turnover: 27 Lacs
% Change: -71.52% (Prev Turnover: 95)

💹 EOD Valuation

P/E Ratio: 22.49
P/B Ratio: 3.11
Market Cap: 630 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: KILITCH
Market Cap: 593 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 500.00
52 Week Low: 265.49

All-Time High: 500.00 Rs.
All-Time Low: 15.65 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-18.12% | -17.98% | 18.07% | 9.91% | 30.16%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 69.23%

Change (3Y | 1Y): 0.98% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 0.00%

Change (3Y | 1Y): 0.00% | 0.00%

DII Holding

DII Holding: 0.00%

Change (3Y | 1Y): 0.00% | 0.00%

Public Holding: 30.77%


🏦 Financial Strength

Debt to Equity: 0.24
Debt: 49.42 Rs. Cr.

Book Value: 115.62 Rs.
Current Ratio: 2.06
Interest Coverage: 8.41
Free Cash Flow: -29.33 Rs. Cr.


📈 Growth & Sales

Sales Growth: 37.52%

Sales Growth Qtr (YOY | QoQ):
28.97% | -29.54%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
30.06% | 20.20% | 37.52%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 122.66%

Profit Growth Qtr (YOY | QoQ):
126.12% | -77.79%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
164.37% | 59.99% | 122.66%


EPS Rs.

EPS (TTM): 16.01 Rs.

EPS Qtr (Last Year | Latest):
0.77 Rs. | 1.73 Rs.

EPS Annual (Last Annual | Annual March):
8.34 Rs. | 15.26 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
162.26% | 58.14%


Net Profit Rs. Cr.

Net Profit (TTM): 26.71 Rs. Cr.

Net Profit (Annual - March): 24.94 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
0.11| 10.22 | 2.27


EBITDA Rs. Cr.

EBITDA (Quarter): 5.82 Rs. Cr.
EBITDA (Previous Yr Ql): 4.23 Rs. Cr.

EBITDA (Annual - March): 42.62 Rs. Cr.
EBITDA (Previous Annual): 27.35 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
73.26% | 52.36%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 15.71%

OPM Qtr (Previous | Current):
23.83% | 7.56%

OPM Annual (5 Yrs | Last Yr | March):
13.23% | 15.72% | 15.86%


Return on Equity %

ROE: 14.10%

ROE (5 Yrs | 3 Yrs | Last Yr):
7.90% | 10.06% | 8.34%


Return on Capital Employed %

ROCE: 17.28%

ROCE (5 Yrs | 3 Yrs | Last Yr):
9.86% | 13.19% | 12.63%


Return on Assets %

ROA (TTM): 9.02%

ROA (5 Yrs | 3 Yrs | Last Yr):
4.48% | 6.03% | 5.50%



PEG Ratio: 0.35
Dividend Yield: 0.00%

PE 3 Yrs: 33.89
PE 5 Yrs: 39.28

Dividend Yield: 0.00%


👥 Company

Kilitch Drugs Ltd

KILITCH

Promoter Holding: %